| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Sumitomo Dainippon Pharma Co. Ltd (F: DPM)
DPM Technical Analysis
5
| As on 10th Mar 2025 DPM STOCK Price closed @ 4.36 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 2.56 & Strong Buy for SHORT-TERM with Stoploss of 2.95 we also expect STOCK to react on Following IMPORTANT LEVELS. |
DPMSTOCK Price
| Open | 4.36 | Change | Price | % |
| High | 4.36 | 1 Day | -0.08 | -1.80 |
| Low | 4.36 | 1 Week | -0.40 | -8.40 |
| Close | 4.36 | 1 Month | 0.86 | 24.57 |
| Volume | 122 | 1 Year | 0.98 | 28.99 |
| 52 Week High 5.05 | 52 Week Low 1.64 | ||||
F Germany Most Active Stocks
| IMU | 0.10 | -99.65% |
| IMU | 0.10 | -99.65% |
| IMU | 0.10 | -99.65% |
| IMU | 0.10 | -99.65% |
| IMU | 0.10 | -99.65% |
| ENB | 47.60 | -0.92% |
| TEF | 3.84 | -0.52% |
| TEF | 3.84 | -0.52% |
| WHL | 5150.00 | -0.44% |
| WDI | 0.05 | -37.50% |
F Germany Top Gainers Stocks
F Germany Top Losers Stocks
| DPM Daily Charts |
DPM Intraday Charts |
Whats New @ Bazaartrend |
DPM Free Analysis |
|
|
DPM Important Levels Intraday
| RESISTANCE | 4.36 |
| RESISTANCE | 4.36 |
| RESISTANCE | 4.36 |
| RESISTANCE | 4.36 |
| RESISTANCE | 4.36 |
| RESISTANCE | 4.36 |
| RESISTANCE | 4.36 |
| RESISTANCE | 4.36 |
DPM Forecast March 2025
| 4th UP Forecast | 5.55 |
| 3rd UP Forecast | 5.17 |
| 2nd UP Forecast | 4.93 |
| 1st UP Forecast | 4.7 |
| 1st DOWN Forecast | 4.02 |
| 2nd DOWN Forecast | 3.79 |
| 3rd DOWN Forecast | 3.55 |
| 4th DOWN Forecast | 3.17 |
DPM Weekly Forecast
| 4th UP Forecast | 4.67 |
| 3rd UP Forecast | 4.57 |
| 2nd UP Forecast | 4.51 |
| 1st UP Forecast | 4.45 |
| 1st DOWN Forecast | 4.27 |
| 2nd DOWN Forecast | 4.21 |
| 3rd DOWN Forecast | 4.15 |
| 4th DOWN Forecast | 4.05 |
DPM Forecast2025
| 4th UP Forecast | 10.93 |
| 3rd UP Forecast | 8.82 |
| 2nd UP Forecast | 7.52 |
| 1st UP Forecast | 6.22 |
| 1st DOWN Forecast | 2.5 |
| 2nd DOWN Forecast | 1.2 |
| 3rd DOWN Forecast | -0.1 |
| 4th DOWN Forecast | -2.21 |
Sumitomo Dainippon Pharma Co. Ltd ( F Germany Symbol : DPM )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
DPM Business Profile
Sumitomo Dainippon Pharma Co., Ltd. manufactures and sells pharmaceuticals, food ingredients and additives, veterinary medicines, diagnostics, and others. The company offers pharmaceutical products, such as therapeutic agents for Parkinson's disease, depression, type 2 diabetes, systemic fungal infection, pruritus, chronic obstructive pulmonary disease, angina pectoris, and arrhythmia. It also provides atypical antipsychotic, antiepileptic, carbapenem antibiotic, and gastroprokine products; and Anderson-Fabry disease drugs. In addition, the company offers food ingredients and additives, such as polysaccharides, and seasonings, such as soups or bouillons; and chemical product materials consisting of pharmaceutical excipients, personal care products, coatings and industrial materials, and electronic materials. Further, it provides veterinary medicines for companion animals, primarily dogs and cats; and livestock comprising cattle, swine, poultry, horses, and aquacultured fish. Sumitomo Dainippon Pharma Co., Ltd. has partnerships with Healios K.K.; Keio University; RIKEN; the Center for iPS Cell Research and Application (CiRA); Kyoto University; and Aikomi Co., Ltd., as well as a joint development agreement with SanBio, Inc; and collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. It also has a strategic research collaboration agreement with Gain Therapeutics, Inc. for the research and development of structurally targeted allosteric regulators to restore functional activity of defective lysosomal enzymes in rare genetic and demyelinating diseases. The company was formerly known as Dainippon Sumitomo Pharma Co., Ltd. and changed its name to Sumitomo Dainippon Pharma Co., Ltd. in June 2014. Sumitomo Dainippon Pharma Co., Ltd. was founded in 1897 and is headquartered in Osaka, Japan. Sumitomo Dainippon Pharma Co., Ltd. is a subsidiary of Sumitomo Chemical Company, Limited. Address: 6-8 Doshomachi 2-chome, Osaka, Japan, 541-0045
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service